摘要
研究胸腺肽对慢性乙型肝炎的治疗作用。治疗组在综合疗法基础上加用胸腺肽注射液,对照组采用综合保肝疗法,疗程均为3 个月。结果:治疗组优于对照组(P< 0-01) 。结论:胸腺肽对乙型肝炎病毒血清学指标(HBV—M)
To study the curative effect of thymosin to treat chronic Hepatitis B,In the contrast group,the multiple Liver-protective therapy was adrpted.And in the experiment group thymosin was added.The course of treatment was three months.Result:The differenle is that the experiment group was better than the contrast group obviously.(P<0.01)Conclusion The experiment shows the adoption of thymosin is effeltive to control the logy of HBV-M
出处
《生物学杂志》
CAS
CSCD
1999年第5期26-27,共2页
Journal of Biology